Keros Therapeutics (KROS) EPS (Basic) Growth (5y) (2024 - 2026)
Powered by 
Analysis
Keros Therapeutics (KROS) EPS (Basic) Growth (5y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn |
| 10 | Keros Therapeutics | 219.98 Mn | -37.62 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.69% |
| Dec 31, 2025 | -0.23% |
| Sep 30, 2025 | 21.38% |
| Jun 30, 2025 | -3.97% |
| Mar 31, 2025 | 22.12% |
| Dec 31, 2024 | 2.22% |
| Sep 30, 2024 | 3.77% |
| Jun 30, 2024 | 2.78% |
| Mar 31, 2024 | 5.57% |